Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.
Open | $3.55 |
Close | $3.48 |
Volume / Avg. | 448.39K / 415.34K |
Day Range | 3.40 - 3.57 |
52 Wk Range | 1.81 - 7.62 |
Market Cap | $210.86M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 66 |
Short Interest | 3.7% |
Days to Cover | 3.92 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Acumen Pharmaceuticals (NASDAQ:ABOS) through any online brokerage.
Other companies in Acumen Pharmaceuticals’s space includes: Molecular Partners (NASDAQ:MOLN), Outlook Therapeutics (NASDAQ:OTLK), Renovaro (NASDAQ:RENB), Atossa Therapeutics (NASDAQ:ATOS) and Opthea (NASDAQ:OPT).
There is no analysis for Acumen Pharmaceuticals.
Acumen Pharmaceuticals has a consensus price target of $13.14.
The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $3.5097 last updated July 26, 2024 at 6:59 PM EDT.
There are no upcoming dividends for Acumen Pharmaceuticals.
Acumen Pharmaceuticals’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Acumen Pharmaceuticals.
Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.